4.3 Article

Targeted proteomics analysis of plasma proteins using recombinant protein standards for addition only workflows

期刊

BIOTECHNIQUES
卷 71, 期 3, 页码 473-483

出版社

FUTURE SCI LTD
DOI: 10.2144/btn-2021-0047

关键词

blood plasma; internal standards; mass spectrometry; multiplex analysis; plasma profiling; room temperature storage; sample preparation; stability; stable Isotope standards; targeted proteomics

资金

  1. Erling Persson Foundation
  2. Knut and Alice Wallenberg Foundation

向作者/读者索取更多资源

This novel approach utilizes isotope-labeled recombinant protein standards stored in a chaotropic agent, allowing storage at ambient temperature, for high-throughput clinical proteome profiling.
Targeted proteomics is an attractive approach for the analysis of blood proteins. Here, we describe a novel analytical platform based on isotope-labeled recombinant protein standards stored in a chaotropic agent and subsequently dried down to allow storage at ambient temperature. This enables a straightforward protocol suitable for robotic workstations. Plasma samples to be analyzed are simply added to the dried pellet followed by enzymatic treatment and mass spectrometry analysis. Here, we show that this approach can be used to precisely (coefficient of variation <10%) determine the absolute concentrations in human plasma of hundred clinically relevant protein targets, spanning four orders of magnitude, using simultaneous analysis of 292 peptides. The use of this next-generation analytical platform for high-throughput clinical proteome profiling is discussed. METHOD SUMMARY Here, we describe a novel approach suitable for routine multiplex measurements of plasma proteins using a mass spectrometry-based protocol, enabled by the use of a chaotropic agent in combination with stable isotope-labeled recombinant protein standards. The method combines established technologies, such as stable isotope methods, generation of recombinant protein standards and mass spectrometry analysis using data independent acquisition with novel use of a chaotropic agent in combination with a vacuum-dried format.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, Research & Experimental

Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases

Hasan Turkez, Ozlem Altay, Serkan Yildirim, Xiangyu Li, Hong Yang, Cemil Bayram, Ismail Bolat, Sena Oner, Ozlem Ozdemir Tozlu, Mehmet Enes Arslan, Muhammad Arif, Burak Yulug, Lutfu Hanoglu, Seyda Cankaya, Simon Lam, Halil Aziz Velioglu, Ebru Coskun, Ezgi Idil, Rahim Nogaylar, Ahmet Ozsimsek, Ahmet Hacimuftuoglu, Saeed Shoaie, Cheng Zhang, Jens Nielsen, Jan Boren, Mathias Uhlen, Adil Mardinoglu

Summary: The study indicates that neurodegenerative diseases are associated with metabolic abnormalities. The administration of combined metabolic activators (CMA) improves metabolic disorders in animal models of Alzheimer's disease (AD) and Parkinson's disease (PD). CMA treatment shows promising results in improving neurological and metabolic parameters in NDDs.

LIFE SCIENCES (2023)

Article Biotechnology & Applied Microbiology

Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models

Rosa Lundbye Allesoe, Agnete Troen Lundgaard, Ricardo Hernandez Medina, Alejandro Aguayo-Orozco, Joachim Johansen, Jakob Nybo Nissen, Caroline Brorsson, Gianluca Mazzoni, Lili Niu, Jorge Hernansanz Biel, Valentas Brasas, Henry Webel, Michael Eriksen Benros, Anders Gorm Pedersen, Piotr Jaroslaw Chmura, Ulrik Plesner Jacobsen, Andrea Mari, Robert Koivula, Anubha Mahajan, Ana Vinuela, Juan Fernandez Tajes, Sapna Sharma, Mark Haid, Mun-Gwan Hong, Petra B. Musholt, Federico De Masi, Josef Vogt, Helle Krogh Pedersen, Valborg Gudmundsdottir, Angus Jones, Gwen Kennedy, Jimmy Bell, E. Louise Thomas, Gary Frost, Henrik Thomsen, Elizaveta Hansen, Tue Haldor Hansen, Henrik Vestergaard, Mirthe Muilwijk, Marieke T. Blom, Leen M. T. Hart, Francois Pattou, Violeta Raverdy, Soren Brage, Tarja Kokkola, Alison Heggie, Donna McEvoy, Miranda Mourby, Jane Kaye, Andrew Hattersley, Timothy McDonald, Martin Ridderstrale, Mark Walker, Ian Forgie, Giuseppe N. Giordano, Imre Pavo, Hartmut Ruetten, Oluf Pedersen, Torben Hansen, Emmanouil Dermitzakis, Paul W. Franks, Jochen M. Schwenk, Jerzy Adamski, Mark McCarthy, Ewan Pearson, Karina Banasik, Simon Rasmussen, Soren Brunak

Summary: The application of multiple omics technologies in biomedical cohorts can reveal patient-level disease characteristics and individualized response to treatment. We developed a deep-learning-based framework, MOVE, to integrate and analyze multi-omics data from a cohort of newly diagnosed type 2 diabetes patients. By using in silico perturbations, we identified drug-omics associations in the multi-modal datasets with higher sensitivity than univariate statistical tests.

NATURE BIOTECHNOLOGY (2023)

Article Nutrition & Dietetics

Ellagic Acid and Its Metabolites as Potent and Selective Allosteric Inhibitors of Liver Pyruvate Kinase

Umberto Maria Battisti, Chunixa Gao, Fady Akladios, Woonghee Kim, Hong Yang, Cemil Bayram, Ismail Bolat, Metin Kiliclioglu, Nursena Yuksel, Ozlem Ozdemir Tozlu, Cheng Zhang, Jihad Sebhaoui, Shazia Iqbal, Saeed Shoaie, Ahmet Hacimuftuoglu, Serkan Yildirim, Hasan Turkez, Mathias Uhlen, Jan Boren, Adil Mardinoglu, Morten Grotli

Summary: This study presents a new finding that ellagic acid and its derivatives can selectively and potently inhibit liver pyruvate kinase, which may open up new therapeutic options for non-alcoholic fatty liver disease (NAFLD).

NUTRIENTS (2023)

Article Neurosciences

Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial

Burak Yulug, Ozlem Altay, Xiangyu Li, Lutfu Hanoglu, Seyda Cankaya, Simon Lam, Halil Aziz Velioglu, Hong Yang, Ebru Coskun, Ezgi Idil, Rahim Nogaylar, Ahmet Ozsimsek, Cemil Bayram, Ismail Bolat, Sena Oner, Ozlem Ozdemir Tozlu, Mehmet Enes Arslan, Ahmet Hacimuftuoglu, Serkan Yildirim, Muhammad Arif, Saeed Shoaie, Cheng Zhang, Jens Nielsen, Hasan Turkez, Jan Boren, Mathias Uhlen, Adil Mardinoglu

Summary: A clinical trial was conducted to study the effect of combined metabolic activators (CMA) on Alzheimer's disease (AD) patients. The results showed that CMA can improve cognitive functions and clinical parameters associated with AD. This study provides evidence for the use of CMA in the treatment of AD.

TRANSLATIONAL NEURODEGENERATION (2023)

Article Mathematical & Computational Biology

Metabolic modelling of the human gut microbiome in type 2 diabetes patients in response to metformin treatment

Bouchra Ezzamouri, Dorines Rosario, Gholamreza Bidkhori, Sunjae Lee, Mathias Uhlen, Saeed Shoaie

Summary: The human gut microbiome plays a significant role in metabolic disorders, such as type 2 diabetes mellitus. This study investigates the mechanistic role of the gut microbiome in response to metformin treatment, using metagenomics data and genome-scale metabolic modeling. The results demonstrate the commensal and competing behavior of key bacterial species in response to metformin and highlight the impact of different nutritional environments.

NPJ SYSTEMS BIOLOGY AND APPLICATIONS (2023)

Article Multidisciplinary Sciences

Targeted proteomics using stable isotope labeled protein fragments enables precise and robust determination of total apolipoprotein(a) in human plasma

Andreas Hober, Mirela Rekanovic, Bjorn Forsstrom, Sara Hansson, David Kotol, Andrew J. Percy, Mathias Uhlen, Jan Oscarsson, Fredrik Edfors, Tasso Miliotis

Summary: This study presents a novel quantitative approach to determine the absolute concentration of apo(a) in two microliters of plasma using proteotypic peptides, which meets the requirements for targeted proteomics assays. The assay parameters were optimized, and the LC-SRM/MS results were compared with a commercially available immunoassay.

PLOS ONE (2023)

Article Multidisciplinary Sciences

Multiplexed selectivity screening of anti-GPCR antibodies

Leo Dahl, Ilana B. Kotliar, Annika Bendes, Tea Dodig-Crnkovic, Samuel Fromm, Arne Elofsson, Mathias Uhlen, Thomas P. Sakmar, Jochen M. Schwenk

Summary: A multiplexed immunoassay was developed to test the selectivity of over 400 anti-GPCR antibodies. The results showed that about 61% of the antibodies were selective, 11% bound off-target, and 28% did not bind to any GPCR. It was also found that on-target antibodies had longer, more disordered antigens and were less buried in the interior of GPCR proteins compared to other antibodies.

SCIENCE ADVANCES (2023)

Editorial Material Endocrinology & Metabolism

Revisiting the role of serine metabolism in hepatic lipogenesis

Hong Yang, Cheng Zhang, Hasan Turkez, Mathias Uhlen, Jan Boren, Adil Mardinoglu

NATURE METABOLISM (2023)

Article Chemistry, Analytical

Assessing the Role of Trypsin in Quantitative Plasma and Single-Cell Proteomics toward Clinical Application

Jakob Woessmann, Valdemaras Petrosius, Nil Uresin, David Kotol, Pedro Aragon-Fernandez, Andreas Hober, Ulrich auf dem Keller, Fredrik Edfors, Erwin M. Schoof

Summary: Mass spectrometry-based bottom-up proteomics is widely used in biomedical studies, with trypsin being the most commonly used protease. However, the technical impact of trypsin digestion and its possible biases are becoming increasingly relevant. In this study, we evaluated the impact of eight commercially available trypsins on various proteomics experiments and provided suggestions for their handling in large-scale studies.

ANALYTICAL CHEMISTRY (2023)

Review Biotechnology & Applied Microbiology

Sequential sequencing by synthesis and the next-generation sequencing revolution

Mathias Uhlen, Stephen R. Quake

Summary: The impact of next-generation sequencing (NGS) is of great significance in the field of life science, contributing to our understanding of human health, disease, biology, and ecology. The majority of NGS systems are based on the concept of 'sequencing by synthesis' (SBS), which uses engineered DNA polymerase for sequential detection of nucleotide incorporation. This review discusses some key concepts leading to the development of NGS technology.

TRENDS IN BIOTECHNOLOGY (2023)

Article Oncology

Absolute Quantification of Pan-Cancer Plasma Proteomes Reveals Unique Signature in Multiple Myeloma

David Kotol, Jakob Woessmann, Andreas Hober, Maria Bueno Alvez, Khue Hua Tran Minh, Fredrik Ponten, Linn Fagerberg, Mathias Uhlen, Fredrik Edfors

Summary: This study utilized mass spectrometry to study proteins in the blood samples of cancer patients and identified potential markers for diagnosing multiple myeloma. By using machine learning and differential expression analysis, a high-accuracy diagnostic model was established, which has significant implications for diagnostic tools in cancer research.

CANCERS (2023)

Article Biology

Metabolite interactions in the bacterial Calvin cycle and implications for flux regulation

Emil Sporre, Jan Karlsen, Karen Schriever, Johannes Asplund-Samuelsson, Markus Janasch, Linnea Strandberg, Anna Karlsson, David Kotol, Luise Zeckey, Ilaria Piazza, Per-Olof Syren, Fredrik Edfors, Elton P. Hudson

Summary: Metabolite-level regulation of enzyme activity is important for microbes to cope with environmental shifts. By using limited proteolysis-small molecule mapping method, this study finds that the interactions between metabolites and proteins show species-specific patterns in different bacteria. It is also discovered that the intermediate metabolites of the Calvin cycle can regulate enzyme activity under different conditions, suggesting that metabolite-level regulation of the Calvin cycle is more prevalent than previously appreciated.

COMMUNICATIONS BIOLOGY (2023)

暂无数据